These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 39321506)

  • 21. New approaches to target cancer stem cells: current scenario.
    Insan MB; Jaitak V
    Mini Rev Med Chem; 2014 Jan; 14(1):20-34. PubMed ID: 24195662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging agents that target signaling pathways in cancer stem cells.
    Yang Y; Li X; Wang T; Guo Q; Xi T; Zheng L
    J Hematol Oncol; 2020 May; 13(1):60. PubMed ID: 32456660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrogel microstructure live-cell array for multiplexed analyses of cancer stem cells, tumor heterogeneity and differential drug response at single-element resolution.
    Afrimzon E; Botchkina G; Zurgil N; Shafran Y; Sobolev M; Moshkov S; Ravid-Hermesh O; Ojima I; Deutsch M
    Lab Chip; 2016 Mar; 16(6):1047-62. PubMed ID: 26907542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel therapeutic strategies for targeting liver cancer stem cells.
    Oishi N; Wang XW
    Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer stem cells and strategies for targeted drug delivery.
    Cao J; Bhatnagar S; Wang J; Qi X; Prabha S; Panyam J
    Drug Deliv Transl Res; 2021 Oct; 11(5):1779-1805. PubMed ID: 33095384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding and targeting cancer stem cells: therapeutic implications and challenges.
    Chen K; Huang YH; Chen JL
    Acta Pharmacol Sin; 2013 Jun; 34(6):732-40. PubMed ID: 23685952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
    Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
    Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Advances in Lung Stem Cells and Lung Cancer Stem Cells].
    Yin H; Deng J
    Zhongguo Fei Ai Za Zhi; 2015 Oct; 18(10):633-9. PubMed ID: 26483336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting cancer stem cells by using the nanoparticles.
    Hong IS; Jang GB; Lee HY; Nam JS
    Int J Nanomedicine; 2015; 10(Spec Iss):251-60. PubMed ID: 26425092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.
    Hong IS; Lee HY; Nam JS
    Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer stem cells and their niche in the progression of squamous cell carcinoma.
    Oshimori N
    Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015).
    Kharkar PS
    Expert Opin Ther Pat; 2017 Jul; 27(7):753-761. PubMed ID: 28460551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer.
    Zeng Z; Fu M; Hu Y; Wei Y; Wei X; Luo M
    Mol Cancer; 2023 Oct; 22(1):172. PubMed ID: 37853437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The challenge of targeting cancer stem cells to halt metastasis.
    Agliano A; Calvo A; Box C
    Semin Cancer Biol; 2017 Jun; 44():25-42. PubMed ID: 28323021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of stiffness and physico-chemical properties of tumour microenvironment on breast cancer cell stemness.
    Shah L; Latif A; Williams KJ; Tirella A
    Acta Biomater; 2022 Oct; 152():273-289. PubMed ID: 36087866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting Cancer Stem Cells Pathways for the Effective Treatment of Cancer.
    Dwivedi AR; Thakur A; Kumar V; Skvortsova I; Kumar V
    Curr Drug Targets; 2020; 21(3):258-278. PubMed ID: 31433755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
    Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX
    Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eliminating Cancer Stem-Like Cells in Oral Cancer by Targeting Elementary Signaling Pathways.
    Joshi J; Patel H; Bhavnagari H; Tarapara B; Pandit A; Shah F
    Crit Rev Oncog; 2022; 27(4):65-82. PubMed ID: 37199303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Notch to target cancer stem cells.
    Pannuti A; Foreman K; Rizzo P; Osipo C; Golde T; Osborne B; Miele L
    Clin Cancer Res; 2010 Jun; 16(12):3141-52. PubMed ID: 20530696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.